IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $4,694,000 | +117.0% | 101,161 | +54.0% | 0.76% | +67.7% |
Q3 2020 | $2,163,000 | +21.7% | 65,707 | +1.5% | 0.45% | +19.6% |
Q2 2020 | $1,778,000 | -29.9% | 64,755 | -23.6% | 0.38% | -50.7% |
Q1 2020 | $2,538,000 | +8.0% | 84,785 | -0.1% | 0.77% | +58.6% |
Q4 2019 | $2,349,000 | +54.4% | 84,874 | +1.6% | 0.48% | +19.6% |
Q3 2019 | $1,521,000 | -26.5% | 83,563 | -1.0% | 0.40% | -23.6% |
Q2 2019 | $2,070,000 | – | 84,405 | – | 0.53% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |